Items Tagged ‘pegph2’

October 7th, 2014

FDA Grants Orphan Drug Designation to Investigational Agent for Pancreatic Cancer


Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people are diagnosed with pancreatic cancer in the United States and close to 37,000 die from the disease. The disease is often diagnosed at an advanced stage, and treatment of advanced disease remains challenging. The current standard of care consists of […]

View full entry

Tags: News, Pancreatic Cancer, pegph2, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer